Dr. Guha K. Venkatraman, MD

Dr. Venkatraman practices at Neurological Institute Of Northern New Jersey in Livingston, New Jersey.

Dr. Venkatraman's NPI, 1356517593, was assigned on May 7, 2008. Dr. Venkatraman holds New Jersey license 25MA08883100.

Dr. Venkatraman's primary practice is Neurological Institute of Northern New Jersey, at 340 E Northfield Rd, Livingston, NJ 07039. The practice phone is (973) 974-9946.

Dr. Venkatraman's primary practice is Neurological Institute Of Northern New Jersey in Livingston, New Jersey. Dr. Venkatraman is also affiliated with Cooperman Barnabas Medical Center. The medical group on file is The Neurological Institute of Northern New Jersey. Dmand AI also links Dr. Venkatraman to 3 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venkatraman practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Venkatraman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Venkatraman's licenses on file in 4 states: New Jersey, Florida, Montana and New Hampshire.

CMS data shows 2,015 Medicare services from Dr. Venkatraman across 13 procedure codes in 2024, for 550 Medicare patients. Medicare paid $255,903 for them.

CMS counts 550 Medicare patients who saw Dr. Venkatraman in 2024. The largest group is 75 to 84, with 228 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venkatraman's median patient age at 66, with 53% women.

In 2024, Dr. Venkatraman wrote 1,092 Medicare Part D claims for 250 patients. 86% of them were for generic drugs. CMS names the drug for 893 of them, across 32 drugs with 11 or more claims each, at $548,593 in total drug cost. In 2023, CMS named 263 claims across 13 drugs.

Dr. Venkatraman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Venkatraman as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Venkatraman in 2011. Dr. Venkatraman's most frequent co-authors are Andrew Bauerschmidt, MD, Arjuna Prasad Mannam, MD and Yedatore S. Venkatesh, MD.

CMS Open Payments shows 227 general payments to Dr. Venkatraman from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Allergan Inc. paid the most, $8,024.